Warning: The NCBI web site requires JavaScript to function. more...
Putative growth characteristics of micrometastatic breast cancer.
Chambers AF, Goss PE.
Breast Cancer Res. 2008;10(6):114. Epub 2008 Nov 27.
Related citations
Tumour dormancy: findings and hypotheses from clinical research on breast cancer.
Demicheli R.
Semin Cancer Biol. 2001 Aug;11(4):297-306. Review.
Tumor dormancy and cancer stem cells: implications for the biology and treatment of breast cancer metastasis.
Allan AL, Vantyghem SA, Tuck AB, Chambers AF.
Breast Dis. 2006-2007;26:87-98. Review.
Proposal for a new model of breast cancer metastatic development.
Demicheli R, Retsky MW, Swartzendruber DE, Bonadonna G.
Ann Oncol. 1997 Nov;8(11):1075-80. Review.
Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer.
Retsky MW, Demicheli R, Hrushesky WJ, Baum M, Gukas ID.
APMIS. 2008 Jul-Aug;116(7-8):730-41. Review.
Tumor cell dormancy: implications for the biology and treatment of breast cancer.
Fehm T, Mueller V, Marches R, Klein G, Gueckel B, Neubauer H, Solomayer E, Becker S.
APMIS. 2008 Jul-Aug;116(7-8):742-53. Review.
Cancer stem cells in breast cancer and metastasis.
Lawson JC, Blatch GL, Edkins AL.
Breast Cancer Res Treat. 2009 Nov;118(2):241-54. Review.
Does tumour dormancy offer a therapeutic target?
Goss PE, Chambers AF.
Nat Rev Cancer. 2010 Dec;10(12):871-7. Epub 2010 Nov 4. Review.
Tumor dormancy and surgery-driven interruption of dormancy in breast cancer: learning from failures.
Demicheli R, Retsky MW, Hrushesky WJ, Baum M.
Nat Clin Pract Oncol. 2007 Dec;4(12):699-710. Review.
Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches.
McGowan PM, Kirstein JM, Chambers AF.
Future Oncol. 2009 Sep;5(7):1083-98. Review.
Effect of breast-duct anatomy and wound-healing responses on local tumour recurrence after primary surgery for early breast cancer.
Mannino M, Yarnold J.
Lancet Oncol. 2009 Apr;10(4):425-9. Review.
Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
Karam AK, Stempel M, Barakat RR, Morrow M, Gemignani ML.
Gynecol Oncol. 2009 Mar;112(3):490-5. Epub 2008 Dec 20.
Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance.
Fehm T, Müller V, Alix-Panabières C, Pantel K.
Breast Cancer Res. 2008;10 Suppl 1:S1. Epub 2008 Apr 9. Review.
High expression of maspin is associated with early tumor relapse in breast cancer.
Joensuu KM, Leidenius MH, Andersson LC, Heikkilä PS.
Hum Pathol. 2009 Aug;40(8):1143-51. Epub 2009 May 8.
New clinical and experimental approaches for studying tumor dormancy: does tumor dormancy offer a therapeutic target?
Goss P, Allan AL, Rodenhiser DI, Foster PJ, Chambers AF.
APMIS. 2008 Jul-Aug;116(7-8):552-68. Review.
Solitary cancer cells as a possible source of tumour dormancy?
Naumov GN, MacDonald IC, Chambers AF, Groom AC.
Semin Cancer Biol. 2001 Aug;11(4):271-6. Review.
Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Kataja V, Castiglione M; ESMO Guidelines Working Group.
Ann Oncol. 2008 May;19 Suppl 2:ii11-3. No abstract available.
[Minimal residual disease in breast cancer: detection and clinical relevance].
Pantel K, Wölfle U.
Verh Dtsch Ges Pathol. 2005;89:68-75. German.
New concepts in breast cancer emerge from analyzing clinical data using numerical algorithms.
Retsky M.
Int J Environ Res Public Health. 2009 Jan;6(1):329-48. Epub 2009 Jan 20.
Breast cancer dormancy can be maintained by small numbers of micrometastases.
Willis L, Alarcón T, Elia G, Jones JL, Wright NA, Tomlinson IP, Graham TA, Page KM.
Cancer Res. 2010 Jun 1;70(11):4310-7. Epub 2010 May 25.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on